Adjuvant radiotherapy in patients with pathologic stage C (pT3N0) adenocarcinoma of the prostate

By Petrovich Z.   Lieskovsky G.   Langholz B.   Bochner B.   Formenti S.   Streeter O.   Skinner D.G.  

Urology, Vol. 53, Iss. 6, 1999-06 ,pp. : 1184-1193

Elsevier

Access to resources Recommend Favorite

Do the current subclassifications of stage T3 adenocarcinoma of the prostate have clinical relevance?

By Corn B.W.   Hanks G.E.   Lee W.R.   Schultheiss T.  

Urology, Vol. 45, Iss. 3, 1995-03 ,pp. : 484-490

Elsevier

Access to resources Recommend Favorite

Durable efficacy of early postoperative radiation therapy for high-risk pT3N0 prostate cancer: the importance of radiation dose - analysis of tumor response and prognosis

By Valicenti R.K.   Gomella L.G.   Ismail M.   Mulholland S.G.   Strup S.   Petersen R.O.   Corn B.W.   Lu J.D.  

Urology, Vol. 52, Iss. 6, 1998-12 ,pp. : 1034-1040

Elsevier

Access to resources Recommend Favorite

Do the results of systematic biopsies predict outcome in patients with T1-T2 prostate cancer treated with radiation therapy alone?

By Lee W.R.   Hanlon A.   Hanks G.E.  

Urology, Vol. 47, Iss. 5, 1996-05 ,pp. : 704-707

Elsevier

Access to resources Recommend Favorite

Long-term follow-up after triple treatment of prostate cancer stage pT3

By Schelin Sonny   Madsen Mikael   Palmqvist Elisabeth   Makela Erik   Klintenberg Claes   Aus Gunnar  

Scandinavian Journal of Urology and Nephrology, Vol. 43, Iss. 3, 2009-04 ,pp. : 186-191

Informa Healthcare

Access to resources Recommend Favorite